![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
J Singh, RK Dubey and CK Atal
Piperine (1-peperoyl piperidine), a major component of the Piper species was reported recently by us to inhibit the activities of rat hepatic monooxygenases and UDP-glucuronyltransferase. This study explores further the basis of inhibition of glucuronidation. The effect of piperine on the rate of glucuronidation of 3-hydroxybenzo(a) pyrene and UDP-glucuronic acid content in the intact isolated epithelial cells of the guinea-pig small intestine was studied. The cells offered a fairly good system to study the modulation of glucuronidation activity. Glucuronidation of 3-hydroxybenzo(a) pyrene was dependent on the time of incubation, cellular protein and substrate concentration. From the kinetics of glucuronidation of 3-hydroxybenzo(a)pyrene in the isolated cell preparation the Vmax of 0.5 nmol of BP-3-glucuronide formed per min/mg of protein and Km of 25 microM were observed. The endogeneous concentration of UDP-glucuronic acid observed was 1.6 to 2.3 nmol/mg of cellular protein. Piperine caused a concentration-related decrease in UDP-glucuronic acid content and the rate of glucuronidation in the cells. It required much lower concentrations of piperine than D- galactosamine to diminish the endogeneous level of UDP-glucuronic acid. Rate of glucuronidation of 3-hydroxybenzo (a) pyrene was dependent on the endogeneous level of UDP-glucuronic acid. At 50 microM piperine, the rate of glucuronidation was reduced to about 50% of the basal rate. Piperine caused noncompetitive inhibition of hepatic microsomal UDP- glucuronyltransferase with Ki of 70 microM. The studies demonstrate that piperine modifies the rate of glucuronidation by lowering the endogeneous UDP-glucuronic acid content and also by inhibiting the transferase activity.
This article has been cited by other articles:
|
|
 |
|
  J. C. Sacco, H.-J. Lehmler, L. W. Robertson, W. Li, and M. O. James Glucuronidation of Polychlorinated Biphenylols and UDP-Glucuronic Acid Concentrations in Channel Catfish Liver and Intestine Drug Metab. Dispos., April 1, 2008; 36(4): 623 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Khan, Z. M. Mirza, A. Kumar, V. Verma, and G. N. Qazi Piperine, a Phytochemical Potentiator of Ciprofloxacin against Staphylococcus aureus Antimicrob. Agents Chemother., February 1, 2006; 50(2): 810 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Lambert, J. Hong, D. H. Kim, V. M. Mishin, and C. S. Yang Piperine Enhances the Bioavailability of the Tea Polyphenol (-)-Epigallocatechin-3-gallate in Mice J. Nutr., August 1, 2004; 134(8): 1948 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Bhardwaj, H. Glaeser, L. Becquemont, U. Klotz, S. K. Gupta, and M. F. Fromm Piperine, a Major Constituent of Black Pepper, Inhibits Human P-glycoprotein and CYP3A4 J. Pharmacol. Exp. Ther., August 1, 2002; 302(2): 645 - 650. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
